-
Novo Nordisk reaches settlement with Mylan Pharmaceuticals over patent dispute over weight loss drug Ozempic and Wegovy
Novo Nordisk has reached a settlement with Mylan Pharmaceuticals regarding the patent dispute over the weight loss drugs Ozempic and Wegovy. Novo Nordisk and Mylan Pharmaceuticals, a subsidiary of Vi ... -
Will the sales director of Novo Nordisk protest due to emotional disputes? Company response: Personal dispute
Recently, a video of Cheng, the sales director of Novo Nordisk China, being protested by a woman in red at an academic conference has been circulating online, causing heated discussions. Afterwards, ...